Computational Biologist

Inflammation

Pfizer, Inc. (New York, NY)

Computational drug design, using both structural and genetic methods.

Computationally design, and then synthesize, rigidified cyclic peptides that mimic the Cα-Cβ vectors of β-turns found in the protein data bank (PDB). These compounds were classified generically to enable substitution of any 4 amino acid sequence for each β-turn type.
Developed a refined systems biology model of inflammation pathways in an effort to increase success rate of compound put into clinical trials.

2008 National Academies Science and Policy Fellowship Recipient

2007 Young Scientist Program Mentor Award Recipient

2006 NIH National Graduate Student Research Festival, funded participant

2003-2005 Computational Biology Training Grant

2002-2004 Siteman Cancer Center Research Pathway Grant